Immunophenotyping and Differential Diagnosis of Hairy Cell Leukemia

Hematology/Oncology Clinics of North America

Volumn 20, Issue 5, 2006, Pages 1051-1063

  Matutes, Estella ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALEMTUZUMAB; CD19 ANTIGEN; CD20 ANTIBODY; CD22 ANTIGEN; CD52 ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY; PURINE DERIVATIVE; RITUXIMAB; TUMOR MARKER;

ANTIGEN EXPRESSION; B LYMPHOCYTE ACTIVATION; CANCER CYTODIAGNOSIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FLOW CYTOMETRY; GIEMSA STAIN; HAIRY CELL LEUKEMIA; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; MEMORY CELL; PATIENT MONITORING; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SPLENOMEGALY; T CELL LYMPHOMA; TISSUE FIXATION; TISSUE SECTION; TREATMENT RESPONSE;

B-LYMPHOCYTES; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL; LEUKEMIA, HAIRY CELL; TUMOR MARKERS, BIOLOGICAL;

EID: 33748593104     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2006.06.012     Document Type: Review

References (46)

1. Bouroncle B.A., Wiseman B.K., and Doan C.A. Leukemic reticuloendotheliosis. Blood 13 (1958) 609-630
2. Foucar K., and Catovsky D. Hairy cell leukaemia. In: Jaffe E.S., Harris N.L., Stein H., et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon (France) 138-141
3. Korsmeyer S.J., Greene W.C., Cossman J., et al. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A 80 (1983) 4522-4526
4. Cawley J.C., Burns G.F., and Hayhoe F.G.J. A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy cell leukemia. Leuk Res 4 (1980) 547-559
5. Sainati L., Matutes E., Mulligan S., et al. A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients. Blood 76 (1990) 157-162
6. Zinzani P.L., Lauria F., Buzzi M., et al. Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases. Haematologica 75 (1990) 54-57
7. Yam L.T., Li C.Y., and Lam K.W. Tartrate resistant acid phosphatase isoenzyme in the reticulum cells of leukaemic reticuloendotheliosis. N Engl J Med 284 (1971) 357-360
8. Drexler H.G., and Gignac S.M. Characterisation and expression of tartrate-resistant acid phosphatase (TRAP) in hematopoietic cells. Leukaemia 8 (1994) 359-368
9. Hoyer J.D., Li C.Y., Yam L.T., et al. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukaemia and other hematologic disorders. Am J Clin Pathol 108 (1997) 308-315
10. Baso K., Liso A., Tiacci E., et al. Gene expression profiling of hairy cell leukaemia reveals a phenotype related to memory B-cells with altered expression of chemokine and adhesion receptors. J Exp Med 199 (2004) 59-68
11. Miranda R.N., Cousar J.B., Hammer R.D., et al. Somatic mutation analysis of IGH variable regions reveal that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma and some hairy cell leukemia are composed of memory B lymphocytes. Hum Pathol 30 (1999) 306-312
12. Brito-Babapulle V., Matutes E., and Catovsky D. Cytogenetics, molecular genetics and immunophenotyping in hairy cell leukaemia. In: Tallman M.S., and Polliack A. (Eds). Hairy cell leukaemia. Advances in blood disorders vol. 5 (2000), Harwood Academic Publishers, Amsterdam 49-64
13. Kluin-Nelemans H.C., Krouwels M.M., Jansen J.H., et al. Hairy cell leukemia preferentially expresses the IgG3 subclass. Blood 75 (1990) 972-975
14. Kinashi T., Godal T., Noma Y., et al. Human neoplastic B cells express more than two isotypes of immunoglobulins without deletion of heavy constant region genes. Genes Dev 1 (1987) 465-470
15. Kayano H., Dyer M.J.S., Zani V.J., et al. Aberrant rearrangements within the immunoglobulin heavy chain locus in hairy cell leukemia. Leuk Lymphoma 14 Suppl 1 (1994) 41-47
16. Forconi F., Sahota S.S., Raspadori D., et al. Hairy cell leukaemia: at a crossroad of somatic mutation and isotype switch. Blood 104 (2004) 3312-3316
17. Matutes E., Owusu-Ankomah K., Morilla R., et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8 (1994) 1640-1645
18. Delgado J., Matutes E., Morilla A., et al. Diagnostic significance of CD20 and FMC7 expression in B-cell disorders. Am J Clin Pathol 12 (2003) 754-759
19. Zomas A.P., Matutes E., Morilla R., et al. Expression of the immunoglobulin-associated protein B29 in B-cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia 10 (1996) 1966-1970
20. Thompson A.A., Talley J.A., Do H.N., et al. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood 90 (1997) 1387-1394
21. Forconi F., Raspadori D., Lenoci M., et al. Absence of surface CD27 distinguishes hairy cell leukaemia from other leukemic B-cell disorders. Haematologica 90 (2005) 266-268
22. + hairy cell leukaemia. Am J Clin Pathol 120 (2003) 228-235
23. Possnett D.N., Chiorazzi N., and Kunkel H.G. Monoclonal antibodies reactive with hairy cell leukaemia. J Clin Invest 70 (1982) 254-261
24. Visser L., Shaw A., Slupsky J., et al. Monoclonal antibodies reactive with hairy cell leukemia. Blood 74 (1989) 320-325
25. Del Giudice I., Matutes E., Morilla R., et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica 89 (2004) 303-308
26. Munoz L., Nomdedeu J.F., Lopez O., et al. Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica 86 (2001) 1261-1269
27. Matutes E., Morilla R., Owusu-Ankomah K., et al. The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood 83 (1994) 1558-1562
28. Matutes E., Morilla R., Owusu-Ankomah K., et al. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymph 14 Suppl 1 (1994) 57-61
29. Falini B., Tiacci E., Liso A., et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (Anxa1). Lancet 363 (2004) 1869-1870
30. Salomon-Nguyen F., Valensi F., Troussard X., et al. The value of monoclonal antibody DBA44 in the diagnosis of B-lymphoid disorders. Leuk Res 20 (1996) 909-913
31. Ohsawa M., Kanno H., Machii T., et al. Immunoreactivity of neoplastic and non-neoplastic monocytoid B lymphocytes for DBA44 and other antibodies. J Clin Pathol 47 (1994) 928-932
32. Mori N., Murakani Y.I., Shimada S., et al. TIA-1 expression in hairy cell leukemia. Mod Pathol 17 (2004) 840-846
33. + T cells. Blood 76 (1990) 959-964
34. Csanaky G., Matutes E., Vass J.A., et al. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia 11 (1997) 408-415
35. Aziz K.A., Till K.J., Zuzel M., et al. Involvement of CD44-hyaluronan interaction in malignant cell homing and fibronectin synthesis in hairy cell leukemia. Blood 96 (2000) 3161-3167
36. Bosch F., Campo E., Jares P., et al. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukaemia. Br J Haematol 91 (1995) 1025-1030
37. de Boer C.J., Kluin-Neleman S.J.C., Dreef E., et al. Involvement of CCND1 gene in hairy cell leukaemia. Ann Oncol 7 (1996) 251-256
38. Quigley M.M., Bethel K.J., Sharpe R.W., et al. CD52 expression in hairy cell leukemia. Am J Hematol 74 (2003) 227-230
39. Matutes E., Wotherspoon A., Brito-Babapulle V., et al. The natural history and clinico-pathological features of the variant form of hairy cell leukaemia. Leukemia 15 (2001) 184-186
40. Matutes E., Wotherspoon A., and Catovsky D. The variant form of hairy cell leukaemia. Best Pract Res Clin Hematol 16 (2003) 41-56
41. Machii T., Tokumine Y., Inoue R., et al. Predominance of a distinct subtype of hairy cell leukemia in Japan. Leukemia 7 (1993) 181-186
42. Kondo H., Takeuchi H., and Katayama I. Differentiating atypical HCL from HCL-Japanese variant. Leukemia 10 (1996) 384
43. Ellison D.J., Sharpe R.W., Robbins B.A., et al. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 84 (1994) 4310-4315
44. Matutes E., Meeus P., McLennan K., et al. The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long-term follow-up study. Br J Haematol 98 (1997) 375-383
45. Sausville J.E., Salloum R.G., Sorbara L., et al. Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometry immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene. Am J Clin Pathol 119 (2003) 213-217
46. Wheaton S., Tallman M.S., Hakimian D., et al. Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukaemia treated with 2-chlorodeoxyadenosine. Blood 87 (1996) 1556-1560